These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 38429756)

  • 1. PHF5A promotes esophageal squamous cell carcinoma progression via stabilizing VEGFA.
    Chang Z; Jia Y; Gao M; Song L; Zhang W; Zhao R; Yu D; Liu X; Li J; Qin Y
    Biol Direct; 2024 Mar; 19(1):19. PubMed ID: 38429756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hsa_circ_0023984 Regulates Cell Proliferation, Migration, and Invasion in Esophageal Squamous Cancer via Regulating miR-1294/PI3K/Akt/c-Myc Pathway.
    Liang W; Wang C; Wang J; Zhang M
    Appl Biochem Biotechnol; 2022 Sep; 194(9):1-16. PubMed ID: 35522362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IKBIP promotes tumor development via the akt signaling pathway in esophageal squamous cell carcinoma.
    Hu J; Dai C; Ding Z; Pan Y; Lu L; Bao J; Zheng J
    BMC Cancer; 2024 Jun; 24(1):759. PubMed ID: 38914958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CircPDE5A-encoded novel regulator of the PI3K/AKT pathway inhibits esophageal squamous cell carcinoma progression by promoting USP14-mediated de-ubiquitination of PIK3IP1.
    Lei K; Liang R; Liang J; Lu N; Huang J; Xu K; Tan B; Wang K; Liang Y; Wang W; Lin H; Wang M
    J Exp Clin Cancer Res; 2024 Apr; 43(1):124. PubMed ID: 38658954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [PHF5A Promotes Proliferation and Migration of Non-Small Cell Lung Cancer 
by Regulating of PI3K/AKT Pathway].
    Wang H; Liu F; Bai C; Xu N
    Zhongguo Fei Ai Za Zhi; 2023 Jan; 26(1):10-16. PubMed ID: 36792075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-4739 inhibits the malignant behavior of esophageal squamous cell carcinoma cells via the homeobox C10/vascular endothelial growth factor A/phosphatidylinositol 3-kinase/AKT pathway.
    Wu K; Liu Z; Dong C; Gu S; Li L; Wang W; Zhou Y
    Bioengineered; 2022 Jun; 13(6):14066-14079. PubMed ID: 35730500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma
    Hu DX; Sun QF; Xu L; Lu HD; Zhang F; Li ZM; Zhang MY
    World J Gastroenterol; 2022 Jan; 28(4):464-478. PubMed ID: 35125830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JUND facilitates proliferation and angiogenesis of esophageal squamous cell carcinoma cell via MAPRE2 up-regulation.
    Zhang D; Pan G; Cheng N; Sun L; Zhou X; Li C; Zhao J
    Tissue Cell; 2023 Apr; 81():102010. PubMed ID: 36608637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
    Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
    Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
    [No Abstract]   [Full Text] [Related]  

  • 10. Circ_0007624 suppresses the development of esophageal squamous cell carcinoma via targeting miR-224-5p/CPEB3 to inactivate the EGFR/PI3K/AKT signaling.
    Cheng J; Ma H; Yan M; Zhang Z; Xing W
    Cell Signal; 2022 Nov; 99():110448. PubMed ID: 35998761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
    Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
    J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLCD3 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/P21 signaling.
    Wang M; Gao M; Chen Y; Wu J; Wang X; Shu Y
    BMC Cancer; 2023 Sep; 23(1):921. PubMed ID: 37773107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RIT1 suppresses esophageal squamous cell carcinoma growth and metastasis and predicts good prognosis.
    Feng YF; Lei YY; Lu JB; Xi SY; Zhang Y; Huang QT; Wu QL; Wang F
    Cell Death Dis; 2018 Oct; 9(11):1085. PubMed ID: 30348939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
    Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
    J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AKAP12 inhibits esophageal squamous carcinoma cell proliferation, migration, and cell cycle via the PI3K/AKT signaling pathway.
    Li X; Dong H; Zheng Y; Ding S; Li Y; Li H; Huang H; Zhong C; Xie T; Xu Y
    Mol Cell Probes; 2023 Dec; 72():101939. PubMed ID: 37879503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-106b-5p regulates esophageal squamous cell carcinoma progression by binding to HPGD.
    Yang F; Sun Z; Wang D; Du T
    BMC Cancer; 2022 Mar; 22(1):308. PubMed ID: 35317779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EIF3H promotes aggressiveness of esophageal squamous cell carcinoma by modulating Snail stability.
    Guo X; Zhu R; Luo A; Zhou H; Ding F; Yang H; Liu Z
    J Exp Clin Cancer Res; 2020 Aug; 39(1):175. PubMed ID: 32867821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma.
    Xu F; Zhang S; Liu Z; Gu J; Li Y; Wang L; Mao W; Zhu Q; Shou H; Ge D; Lu C
    BMC Cancer; 2019 Sep; 19(1):875. PubMed ID: 31481019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocadherin 8 (PCDH8) Inhibits Proliferation, Migration, Invasion, and Angiogenesis in Esophageal Squamous Cell Carcinoma.
    Yu H; Jiang X; Jiang L; Zhou H; Bao J; Zhu X; Liu F; Huang J
    Med Sci Monit; 2020 Apr; 26():e920665. PubMed ID: 32330123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of fibulin-4 inhibits autophagy and promotes the sensitivity of esophageal squamous cell carcinoma cells to apatinib by activating the Akt-mTOR signaling pathway.
    Chen X; Wang J; Song L; Yu Y; Shi M; Jiang W; Liu X; He X
    Thorac Cancer; 2022 Sep; 13(18):2592-2605. PubMed ID: 35950373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.